In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitized individuals

In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitized individuals

Author Iwai, Leo Kei Autor UNIFESP Google Scholar
Yoshida, Márcia Google Scholar
Sidney, John Google Scholar
Shikanai-Yasuda, Maria Aparecida Google Scholar
Goldberg, Anna Carla Google Scholar
Juliano, Maria Aparecida Autor UNIFESP Google Scholar
Hammer, Jurgen Google Scholar
Juliano, Luiz Autor UNIFESP Google Scholar
Sette, Alessandro Google Scholar
Kalil, Jorge Google Scholar
Travassos, Luiz Rodolpho Autor UNIFESP Google Scholar
Cunha-Neto, Edecio Google Scholar
Institution Universidade de São Paulo (USP)
La Jolla Inst Allergy & Immunol
Hoffmann La Roche Inc
Universidade Federal de São Paulo (UNIFESP)
Abstract One of the major drawbacks limiting the use of synthetic peptide vaccines in genetically distinct populations is the fact that different epitopes are recognized by T cells from individuals displaying distinct major histocompatibility complex molecules. Immunization of mice with peptide (181-195) from the immunodominant 43 kDa glycoprotein of Paracoccidioides brasiliensis (gp43), the causative agent of Paracoccidioidomycosis (PCM), conferred protection against infectious challenge by the fungus. To identify immunodominant and potentially protective human T-cell epitopes in gp43, we used the TEPITOPE algorithm to select peptide sequences that would most likely bind multiple HLA-DR molecules and tested their recognition by T cells from sensitized individuals. The 5 most promiscuous peptides were selected from the gp43 sequence and the actual promiscuity of HLA binding was assessed by direct binding assays to 9 prevalent HLA-DR molecules. Synthetic peptides were tested in proliferation assays with peripheral blood mononuclear cells (PBMC) from PCM patients after chemotherapy and healthy controls. PBMC from 14 of 19 patients recognized at least one of the promiscuous peptides, whereas none of the healthy controls recognized the gp43 promiscuous peptides. Peptide gp43(180-194) was recognized by 53% of patients, whereas the other promiscuous gp43 peptides were recognized by 32% to 47% of patients. The frequency of peptide binding and peptide recognition correlated with the promiscuity of HLA-DR binding, as determined by TEPITOPE analysis. In silico prediction of promiscuous epitopes led to the identification of naturally immunodominant epitopes recognized by PBMC from a significant proportion of a genetically heterogeneous patient population exposed to P. brasiliensis. The combination of several such epitopes may increase the frequency of positive responses and allow the immunization of genetically distinct populations.
Language English
Date 2003-09-01
Published in Molecular Medicine. Manhasset: North Shore-long Island Jewish Research Institute, v. 9, n. 9-12, p. 209-219, 2003.
ISSN 1076-1551 (Sherpa/Romeo, impact factor)
Publisher North Shore-long Island Jewish Research Institute
Extent 209-219
Origin http://molmed.org/journal/articles/25/373
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000222333900004
URI http://repositorio.unifesp.br/11600/44926

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account